Las Vegas Sands (LVS) 45.69 $LVS Is Now the Right Time

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2015 at 6:28 PM

Las Vegas Sands (LVS) 45.69 $LVS

Is Now the Right Time to Buy Las Vegas Sands?
Andrés Cardenal, The Motley Fool - Motley Fool - Thu Nov 12, 4:00PM CST
Source: Las Vegas Sands . Las Vegas Sands is facing considerable challenges due to demand weakness in Macau, a key market for the company. However, the business offers a lot of room for improvement in the middle term, and Las Vegas Sands stock...
WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Las Vegas Sands Helps Drive Support for Homeless Youth During National Homeless Youth Awareness Month
PR Newswire - Thu Nov 12, 11:25AM CST
Las Vegas Sands Corp. (NYSE: LVS) today announced a homeless youth awareness campaign in support of National Homeless Youth Awareness Month. As part of the company's corporate citizenship program Sands Cares, the "Lost Vegas" media campaign, beginning November 15, asks area residents to join the company in delivering support to Nevada Partnership for Homeless Youth (NPHY) by donating or volunteering time to help homeless youth.
LVS: 45.69 (-0.34)

6 Dividend Stocks Investors Are Selling Like Hotcakes
at The Street - Tue Nov 10, 10:08AM CST
While investors have flocked to some dividend stocks recently, they've been dumping others.
BHP: 28.41 (+0.22), BAX: 37.57 (+0.11), VALE: 3.97 (+0.04), BP: 33.38 (-0.12), LVS: 45.69 (-0.34), WIN: 5.53 (-0.62), PSEC: 7.33 (+0.10)

Gaming Stocks Are on a Tear -- Here's Why
Travis Hoium, The Motley Fool - Motley Fool - Tue Nov 10, 9:00AM CST
Image source: Wynn Resorts. After a rough start to the year, the last month has been great for gaming investors. According to S&P Capital IQ data, Caesars Entertainment , Melco Crown , Wynn Resorts , Las Vegas Sands , MGM Resorts ,...
BYD: 19.90 (-0.44), MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29), CZR: 7.94 (+0.27)

Macau slump hits Sands, Wynn
at Investor's Business Daily - Mon Nov 09, 5:54PM CST
Checks with Macau casinos indicate a 30%-34% decline in the Asia gaming hotspot's Nov. revenue vs. a year earlier, Wells Fargo said, worse than its previous estimate for a 30% drop. Wells cited "continued instability" in VIP gaming. Las Vegas Sands...
MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Las Vegas Sands Set to Possibly Rebound After Yesterday's Selloff of 6.37%
Comtex SmarTrend(R) - Mon Nov 09, 4:48PM CST
Las Vegas Sands (NYSE:LVS) traded in a range yesterday that spanned from a low of $46.15 to a high of $48.90. Yesterday, the shares fell 6.4%, which took the trading range below the 3-day low of $49.00 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LVS: 45.69 (-0.34)

SmarTrend Watching for Potential Rebound in Shares of Las Vegas Sands After 6.37% Loss
Comtex SmarTrend(R) - Mon Nov 09, 4:48PM CST
Las Vegas Sands (NYSE:LVS) traded in a range yesterday that spanned from a low of $46.15 to a high of $48.90. Yesterday, the shares fell 6.4%, which took the trading range below the 3-day low of $49.00 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LVS: 45.69 (-0.34)

Sands, Wynn, MGM Dive As Macau Slump Extends
at Investor's Business Daily - Mon Nov 09, 3:34PM CST
Casino stocks got clobbered again Monday on a report projecting more bleak numbers from the world's top gambling destination, Macau, China. Las Vegas Sands (LVS), Wynn Resorts (WYNN) and MGM Resorts International (MGM), as well as Hong Kong's Melco...
MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Stocks End Lower In Light Volume;
at Investor's Business Daily - Mon Nov 09, 3:26PM CST
Stocks ended lower in light volume Monday on concerns that the Federal Reserve appears poised to raise interest rates as early as next month. The Nasdaq, S&P 500 and the Dow Jones industrial average each fell 1%. Volume fell 14% on the Nasdaq and 10%...
DHI: 30.67 (-0.32), ZBRA: 67.71 (-3.33), LNKD: 243.00 (-9.96), LXFT: 73.86 (-2.44), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), DOX: 54.10 (-0.77), MGM: 22.51 (-0.29), PCLN: 1,297.75 (-16.26)

5.8% Return Seen to Date on SmarTrend Las Vegas Sands Call (LVS)
Comtex SmarTrend(R) - Mon Nov 09, 2:13PM CST
SmarTrend identified an Uptrend for Las Vegas Sands (NYSE:LVS) on October 6th, 2015 at $43.98. In approximately 1 month, Las Vegas Sands has returned 5.81% as of today's recent price of $46.53.
LVS: 45.69 (-0.34)

One Reason Why Las Vegas Sands (LVS) Stock Is Lower Today
at The Street - Mon Nov 09, 1:52PM CST
Las Vegas Sands (LVS) shares are lower after Wells Fargo cuts its November forecast for Macau gaming revenue.
LVS: 45.69 (-0.34)

Should You Bet on Casino ETFs after Mixed Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Nov 09, 10:54AM CST
Casino earnings were mixed in Q3; what lies ahead for the casino ETF?
BJK: 32.33 (-0.44), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Is Macau Finally On the Road to Recovery?
Travis Hoium, The Motley Fool - Motley Fool - Sat Nov 07, 12:00PM CST
Macau has been in the dumps for over a year and investors have been looking for a sign that the market is finally hitting bottom. There may be some light at the end of the tunnel after October's gaming numbers were released. The Macau market isn't...
MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34)

Melco Crown Tops Q3 Earnings, Down Y/Y on Both Counts
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 8:02AM CST
Melco Crown Entertainment Limited (MPEL) posted third quarter 2015 results with earnings beating the Zacks Consnensus Estimate while revenues missing the same.
MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Campaign for Accountability Requests Investigation of Sheldon Adelson and Las Vegas Sands' Ties to Chinese Organized Crime
PR Newswire - Tue Nov 03, 9:00AM CST
Today, Campaign for Accountability (CfA) asked the Senate Committee on Homeland Security and Governmental Affairs and the Federal Election Commission to investigate Sheldon Adelson and the Las Vegas Sands Corporation's (LVS) ties to Chinese organized crime in its Macau operations and determine whether illegally laundered foreign funds are making their way into the campaign coffers of American politicians.
LVS: 45.69 (-0.34)

Macau Still Depressed, Studio City A Bright Spot
at Investor's Business Daily - Mon Nov 02, 3:35PM CST
The latest combined revenue numbers for Macau casinos including those run by Las Vegas Sands (LVS), Wynn Resorts (WYNN) and MGM Resorts International (MGM) remained bleak, but a huge new casino project is a bright spot on the horizon, a report said....
MPEL: 17.15 (-0.24), WYNN: 62.20 (-2.50), LVS: 45.69 (-0.34), MGM: 22.51 (-0.29)

Las Vegas Sands Up 15.3% Since SmarTrend Uptrend Call (LVS)
Comtex SmarTrend(R) - Mon Nov 02, 11:45AM CST
SmarTrend identified an Uptrend for Las Vegas Sands (NYSE:LVS) on October 6th, 2015 at $43.98. In approximately 4 weeks, Las Vegas Sands has returned 15.32% as of today's recent price of $50.71.
LVS: 45.69 (-0.34)

Multi-Platinum Singer and Songwriter Carly Rae Jepsen to Ring in 2016 at Venetian Las Vegas Concerts
PR Newswire - Mon Nov 02, 9:00AM CST
Multi-platinum GRAMMY®-nominated singer and songwriter Carly Rae Jepsen will ring in the New Year at Venetian Las Vegas during three concert performances: Dec. 30, and 31, 2015 and Jan. 2, 2016. Jepsen will perform her headline shows inside The Venetian Theatre.
LVS: 45.69 (-0.34)

SmarTrend Watching for Potential Pullback in Shares of Las Vegas Sands After 1.35% Gain
Comtex SmarTrend(R) - Fri Oct 30, 4:18PM CDT
Las Vegas Sands (NYSE:LVS) traded in a range yesterday that spanned from a low of $48.78 to a high of $49.78. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $49.69 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LVS: 45.69 (-0.34)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Stephen A. Smith Calls for Corporate Support of HBCUs

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Gentex Shares Tumble Amid Legal Investigation Concerns

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....